Paysign, Inc. to Sponsor the 2024 Gene Therapy for Rare Disorders Conference March 26-29
Paysign, Inc. (PAYS)
Company Research
Source: Business Wire
BOSTON--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their first-time sponsorship of the 7th Annual Gene Therapy for Rare Disorders conference to be held March 26-29, 2024, in Boston, Massachusetts.In keeping with their commitment to patient affordability and access, Paysign is sponsoring the annual event as an Exhibition Partner. The conference is the gene therapy industry’s leading event where key figures, service providers, payers and regulators discuss insights to the crucial challenges that face these programs today."We are thrilled to add this event to our annual schedule of sponsorships and to provide much-needed representation for patient affordability solutions that tackle the biggest issues facing access to gene therapy for rare disorders,” said Matthew Turner, President, Patient Affordability at Paysign
Show less
Read more
Impact Snapshot
Event Time:
PAYS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PAYS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PAYS alerts
High impacting Paysign, Inc. news events
Weekly update
A roundup of the hottest topics
PAYS
News
- The past five years for Paysign (NASDAQ:PAYS) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Paysign to Host First Quarter 2024 Earnings CallBusiness Wire
- PaySign, Inc. (NASDAQ: PAYS) had its price target raised by analysts at DA Davidson from $4.00 to $4.50. They now have a "buy" rating on the stock.MarketBeat
- Driving Growth And Innovation Are Drivers Of PaySign's Success In The Prepaid Card Industry [Seeking Alpha]Seeking Alpha
- PaySign Full Year 2023 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
PAYS
Sec Filings
- 4/19/24 - Form 8-K
- 3/29/24 - Form 4
- 3/29/24 - Form DEFA14A
- PAYS's page on the SEC website